Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

Radiation and immunology – a new therapeutic partnership

Dr Ralph Weichselbaum - University of Chicago, Chicago, USA
Radiation and immunology – a new therapeutic partnership ( Dr Ralph Weichselbaum - University of Chicago, Chicago, USA )
6 Jul 2015

Meta-analysis confirms benefits and safety of precision medicine

Prof Razelle Kurzrock - University of California, San Diego, USA
Meta-analysis confirms benefits and safety of precision medicine ( Prof Razelle Kurzrock - University of California, San Diego, USA )
3 Jul 2015

TargomiRs show promise in phase I study of malignant mesothelioma

Prof Nico van Zandwijk - University of Sydney, Sydney, Australia
TargomiRs show promise in phase I study of malignant mesothelioma ( Prof Nico van Zandwijk - University of Sydney, Sydney, Australia )
3 Jul 2015

SPECTAlung: improving clinical trial access for patients with thoracic tumours

Dr Jessica Menis and Dr Benjamin Besse
SPECTAlung: improving clinical trial access for patients with thoracic tumours ( Dr Jessica Menis and Dr Benjamin Besse )
3 Jul 2015

Cancer genomics of urothelial cancer and fibroepithelial tumors of the breast

Prof Bin Tean Teh - National Singapore Cancer Center, Singapore
Cancer genomics of urothelial cancer and fibroepithelial tumors of the breast ( Prof Bin Tean Teh - National Singapore Cancer Center, Singapore )
3 Jul 2015

Ibrutinib combined with bendamustine plus rituximab in previously treated CLL and SLL

Dr Paula Cramer - University of Cologne, Köln, Germany
Ibrutinib combined with bendamustine plus rituximab in previously treated CLL and SLL ( Dr Paula Cramer - University of Cologne, Köln, Germany )
30 Jun 2015

Chemoresistance and residual disease promoted by DNMT3A R882 in AML

Dr Olga Guryanova - Memorial Sloan Kettering Cancer Center, New York, USA
Chemoresistance and residual disease promoted by DNMT3A R882 in AML ( Dr Olga Guryanova - Memorial Sloan Kettering Cancer Center, New York, USA )
19 Jun 2015

Comment: Venetoclax with rituxumab highly active in relapsed refractory CLL

Prof Anton Hagenbeek - University Medical Center Utrecht, Utrecht, Netherlands
Comment: Venetoclax with rituxumab highly active in relapsed refractory CLL ( Prof Anton Hagenbeek - University Medical Center Utrecht, Utrecht, Netherlands )
17 Jun 2015

EHA 2015 highlights

Peter Goodwin - ecancer reporter
EHA 2015 highlights ( Peter Goodwin - ecancer reporter )
17 Jun 2015

Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma

Dr Jessica Okosun - Barts Cancer Institute, London, UK
Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma ( Dr Jessica Okosun - Barts Cancer Institute, London, UK )
16 Jun 2015

Biomarkers for childhood relapsed acute lymphoblastic leukaemia

Prof Anthony Moorman - Newcastle University, Newcastle, UK
Biomarkers for childhood relapsed acute lymphoblastic leukaemia ( Prof Anthony Moorman - Newcastle University, Newcastle, UK )
16 Jun 2015

Are CML patients being treated to the correct standard?

Dr Verena Hoffmann - Ludwig Maximilian University, Munich, Germany
Are CML patients being treated to the correct standard? ( Dr Verena Hoffmann - Ludwig Maximilian University, Munich, Germany )
16 Jun 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation